Conversations in Drug Development Trends

FEBRUARY 22, 2023

Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!

Disease 52

Disease Clinical Trials Trials Treatment 52

PPD

SEPTEMBER 16, 2024

The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery.

Clinical Development 52

Clinical Development Clinical Trials Clinical Research Trials 52

Conversations in Drug Development Trends

JUNE 21, 2024

The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Check out this webinar on navigating the landscape of oncology clinical trials.

Clinical Trials 64

Clinical Trials Therapies Clinical Research Immune Response 64

PPD

OCTOBER 16, 2023

This enables deeper and more meaningful real-world insights on clinical study data. Tokenization can accelerate innovation in clinical trials and drug development. Once in the data lake, tokenized data can be linked using a special linking software based on the data usage agreements to create longitudinal patient data.

Clinical Trials 98

Clinical Trials Trials Research Therapies 98

Agency IQ

OCTOBER 27, 2023

Start Date End Date Event Event Type Center 10/30/2023 10/30/2023 Defining ‘Candy-Like’ Nonprescription Drug Products Workshop CDER 10/31/2023 10/31/2023 Cellular, Tissue, and Gene Therapies Advisory Committee Advisory Committee Meeting CBER 10/31/2023 10/31/2023 Webinar – Proposed Rule: Medical Devices; Laboratory Developed Tests (..)

FDA 40

FDA Science Regulations Production 40

Conversations in Drug Development Trends

MAY 1, 2024

For clinical research professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. Check out our recent webinar for a more comprehensive dive into early and ongoing regulatory engagement and how it drives program and commercial success.

Clinical Research 69

Clinical Research Trials Clinical Trials Research 69

Conversations in Drug Development Trends

FEBRUARY 26, 2024

However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success. In our recent Xtalks webinar, “ See How It’s Done: Case Studies on Patient Experience Design ,” our Therapeutic Strategy Lead, Rare Disease, Juliane K.

Clinical Trials 59

Clinical Trials Trials Disease Clinical Research 59

Agency IQ

MARCH 1, 2024

Start Date End Date Event Event Type Center 02/26/2024 02/26/2024 FDA/CDER and American Association of Pharmaceutical Scientists (AAPS) Hybrid Public Workshop Public CDER 02/27/2024 02/27/2024 FDA Oncology Center of Excellence Presents: Conversations on Cancer, Black History Month Program: “Real Talk: Our Stories as Black Oncologists at the FDA” Webcast (..)

FDA 40

FDA Science Clinical Trials Regulations 40

Alta Sciences

JULY 18, 2023

Top Nonclinical Scientific Resources The Altascientist Issue 32: A Changing Paradigm for Non-rodent Species in Nonclinical Safety Studies Though historically used predominantly in dermal and wound healing research, an increasing body of evidence supports the use of miniature swine as a viable non-rodent option for your nonclinical safety studies.

Science 40

Science Clinical Trials FDA Trials 40

Agency IQ

FEBRUARY 2, 2024

Start Date End Date Event Event Type Center 01/10/2024 01/10/2024 FDA Oncology Center of Excellence Presents: Conversations on Cancer: “Bringing Innovation to People Facing Cancer” Webcast Office of the Commissioner 01/26/2024 01/26/2024 Medical Device Sterilization Town Hall: FDA Activities and Challenges in Reducing Reliance on Ethylene Oxide (EtO) (..)

FDA 40

FDA Science Clinical Trials Regulations 40